The digital content on TLO has been updated to align with the accessibility standards required by WCAG 2.1.

Enrolled Bill Summary

Enrolled Bill Summary

Legislative Session: 89(R)

89(R) HB 46

The digital content on TLO has been updated to align with the accessibility standards required by WCAG 2.1.

 

House Bill 46

Effective: 9-1-25

House Author: King et al.

House Committee: Public Health

Senate Sponsor: Perry et al.

Senate Committee: State Affairs

 

House Bill 46 amends the Health and Safety Code and Occupations Code to expand the Texas Compassionate-Use Program by authorizing a licensed dispensing organization to operate one or more satellite locations in addition to the organization's primary location to securely store low-THC cannabis for distribution, requiring the Department of Public Safety (DPS) to issue 15 licenses to dispensing organizations in Texas provided that DPS receives applications from a sufficient number of eligible applicants, requiring DPS to issue and renew licenses to dispensing organizations in a manner that ensures adequate access to low-THC cannabis for patients registered in the compassionate-use registry in each public health region, expanding the medical conditions for which a patient's diagnosis authorizes a physician to prescribe low-THC cannabis for compassionate use, and authorizing a physician to prescribe pulmonary inhalation of an aerosol or vapor as a means of administration of low-THC cannabis under certain circumstances.

House Bill 46, however, also sets out certain restrictions on dispensing and prescribing low-THC cannabis, including by expanding the individuals who must register with DPS with respect to a licensed dispensing organization, prohibiting a dispensing organization from dispensing low-THC cannabis in a package or container that contains more than a total of one gram of tetrahydrocannabinols or in a medical device for pulmonary inhalation that contains more than one gram of tetrahydrocannabinols, prohibiting a dispensing organization from dispensing a low-THC cannabis product that contains a cannabinoid that is not a phytocannabinoid, and limiting prescription quantities. The bill additionally provides for the confidentiality of certain information within the compassionate-use registry.